FDA Approves Gene Therapy for Tough-to-Treat Bladder Cancer

MONDAY, Dec. 19, 2022 -- Patients with a high-risk bladder cancer now have a new option to treat it. The U.S. Food and Drug Administration on Friday approved a gene therapy called Adstiladrin, which is designed to work for patients who have what ’s...
Source: Drugs.com - Daily MedNews - Category: General Medicine Source Type: news